Drug Shortage Report for BLEOMYCIN FOR INJECTION USP

Last updated on 2020-03-21 History
Report ID 105370
Drug Identification Number 02131692
Brand name BLEOMYCIN FOR INJECTION USP
Common or Proper name Bleomycin for Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) BLEOMYCIN
Strength(s) 15UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRA-ARTERIAL INTRACAVITARY INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1 x 15IU GVL
ATC code L01DC
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-05
Estimated end date
Actual end date 2020-03-20
Shortage status Resolved
Updated date 2020-03-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-02-05 English Compare
v2 2020-02-05 English Compare
v3 2020-02-05 French Compare
v4 2020-02-06 English Compare
v5 2020-03-10 English Compare
v6 2020-03-10 French Compare
v7 2020-03-20 English Compare
v8 2020-03-20 French Compare
v9 2020-03-21 English Compare

Showing 1 to 9 of 9